Histiocytosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials
• Forums

Cobimetinib for BRAF-wild-type Histiocytoses
Condition:   Disease or R Group Histiocytoses Interventions:   Drug: Cobimetinib;   Drug: Placebo oral tablet Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2019 Category: Research Source Type: clinical trials